The stock's fall snapped a five-day winning streak.
BTIG analyst Marie Thibault raised the firm’s price target on Boston Scientific (BSX) to $101 from $97 and keeps a Buy rating on the shares as ...
In a report released today, Marie Thibault from BTIG maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target ...
This was the stock's fifth consecutive day of gains.
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's catheters used in a type of ...
Hosted on MSN3d
Boston Scientific, IBD Stock Of The Day, Has Surged 57% In 2024. This Is Why There's More Upside.Boston Scientific is Thursday's IBD Stock Of The Day as the medtech trades just below all-time highs it hit late last month.
The update followed a higher than expected number of reports of esophageal injury after catheter ablation procedures for ...
The FDA is elevating a recall from Boston Scientific covering its cryoablation balloon catheters for the treatment of atrial ...
10don MSN
Devices already in inventory can be used with the updated instructions by doctors. Patients already treated don’t need to do ...
Investor's Business Daily on MSN2d
S&P 500 Winners Fortinet, Boston Scientific Lead 5 Stocks Near Buy PointsS&P 500 components Fortinet and Boston Scientific are among five stocks to watch near buy points as 2024 comes to a close.
The FDA is boosting a recall effort from Boston Scientific regarding batteries potentially underpowering a number of the ...
Boston Scientific Corporation (BSX) stock saw a modest uptick, ending the day at $91.07 which represents a slight increase of $1.21 or 1.35% from the prior close of $89.86. The stock opened at $89.86 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback